Skip to main content
. 2016 Sep 28;29(4):793–800. doi: 10.1007/s40520-016-0630-6

Table 2.

Change in walking speed over time, in the total sample, and by tooth loss status

Change in walking speed (m/s)
Adjusted for demographic factors Adjusted for demographic and lifestyle-related factors, and chronic diseases Adjusted for demographic and lifestyle-related factors, chronic diseases, and CRPa
β-Coefficient (95 % CI) β-Coefficient (95 % CI) β-Coefficient (95 % CI)
Total sample
 Intercept (baseline speed) 1.04 (1.00–1.08) 1.11 (1.06–1.16) 1.12 (0.99–1.25)
 Average change over 3 yearsb −0.06 (−0.08 to −0.04) −0.06 (−0.08 to −0.04) −0.10 (−0.13 to −0.08)
 Average change over 6 years −0.15 (−0.16 to −0.13) −0.15 (−0.16 to −0.14) −0.27 (−0.29 to −0.24)
By tooth loss status
 p value for interaction between time and tooth loss 0.003 0.001 0.603
 Among people with no tooth loss at baseline (n = 2102)
  Intercept (baseline speed) 1.07 (1.02–1.12) 1.12 (1.06–1.17) 1.14 (1.00–1.28)
  Average change over 3 yearsb −0.05 (−0.08 to −0.03) −0.05 (−0.08 to −0.03) −0.10 (−0.13 to −0.06)
  Average change over 6 years −0.14 (−0.15 to −0.12) −0.14 (−0.15 to −0.12) −0.27 (−0.30 to −0.24)
 Among people with partial tooth loss at baseline (n = 389)
  Intercept (baseline speed) 1.03 (0.97–1.08) 1.10 (1.05–1.16) 1.11 (0.96–1.25)
  Average change over 3 yearsb −0.06 (−0.11 to −0.02) −0.07 (−0.11 to −0.02) −0.10 (−0.16 to −0.05)
  Average change over 6 years −0.18 (−0.22 to −0.14) −0.20 (−0.24 to −0.15) −0.25 (−0.31 to −0.20)
 Among people with complete tooth loss at baseline (n = 204)
  Intercept (baseline speed) 0.97 (0.91–1.03) 1.08 (1.01–1.15) 1.12 (0.96–1.29)
  Average change over 3 yearsb −0.13 (−0.19 to −0.07) −0.11 (−0.18 to −0.05) −0.12 (−0.21 to −0.03)
  Average change over 6 years −0.25 (−0.32 to −0.18) −0.26 (−0.33 to −0.19) −0.34 (−0.43 to −0.24)

Demographic factors included age, sex, and education

Lifestyle-related factors included body mass index, smoking, alcohol consumption, and physical exercise

Chronic diseases included cardiovascular disease, stroke, hypertension, diabetes, musculoskeletal disease, dementia, and cancer

CI confidence interval, CRP C-reactive protein

aAdjusted for CRP at baseline and follow-ups

bIncludes only participants aged ≥78 years at baseline